Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 26, Issue 12, 2004, Pages 753-755

  Huang, Jing ^a   Cai, Rui gang ^a   Meng, Ping jun ^a   Zhang, Ming juan ^a   Cui, Chen xu ^a   Yang, Lin ^a   Chu, Da tong ^a   Sun, Yan ^a   Wang, Jin wan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; ESOPHAGUS TUMOR; FEMALE; HUMAN; LIVER TUMOR; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; NEUTROPENIA; PATHOLOGY; PHASE 2 CLINICAL TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; PACLITAXEL; REMISSION INDUCTION; SURVIVAL RATE;

EID: 26944476707     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)